Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 20
Filter
1.
Medicina (B Aires) ; 84(5): 937-945, 2024.
Article in English | MEDLINE | ID: mdl-39399934

ABSTRACT

The definition of quaternary prevention as the set of interventions that avoids or mitigates the consequences of unnecessary or excessive activity of medical interventionism and the health system. The definition of a new disease is a complex process that involves the identification, characterization and description of a medical condition that has not been previously recognized or documented. Since mid-2020, the term chronic COVID/long COVID has been used to describe the presence of signs and symptoms after an acute SARS-CoV-2 infection, with multiple terminologies and definitions in international literature. Post-infectious syndromes, myalgia encephalomyelitis and fibromyalgia, are some of the diseases that have similarities with chronic COVID. This article presents an analysis relating the concepts of new disease and quaternary prevention with chronic COVID and other diseases described in the literature.


Se define prevención cuaternaria como el conjunto de intervenciones que evita o atenúa las consecuencias de la actividad innecesaria o excesiva del intervencionismo médico y del sistema sanitario. La definición de una nueva enfermedad es un proceso complejo que involucra la identificación, caracterización y descripción de un cuadro clínico que no ha sido previamente reconocida o documentada. Desde mediados del año 2020 se utiliza el término COVID crónico/long COVID para describir la presencia de signos y síntomas luego de una infección aguda por SARS-CoV-2, con múltiples terminologías y definiciones en la literatura internacional. Los síndromes posinfecciosos, la encefalomielitis mialgia y la fibromialgia, son algunas de las enfermedades que tienen similitudes con el COVID crónico. En este artículo se presenta un análisis relacionando los conceptos de nueva enfermedad y prevención cuaternaria con el COVID crónico y otras enfermedades descritas en la literatura.


Subject(s)
COVID-19 , Post-Acute COVID-19 Syndrome , Humans , COVID-19/complications , COVID-19/prevention & control , SARS-CoV-2 , Chronic Disease , Fibromyalgia
2.
Front Cell Infect Microbiol ; 14: 1293782, 2024.
Article in English | MEDLINE | ID: mdl-38357446

ABSTRACT

Infectious diseases have consistently served as pivotal influences on numerous civilizations, inducing morbidity, mortality, and consequently redirecting the course of history. Their impact extends far beyond the acute phase, characterized by the majority of symptom presentations, to a multitude of adverse events and sequelae that follow viral, parasitic, fungal, or bacterial infections. In this context, myriad sequelae related to various infectious diseases have been identified, spanning short to long-term durations. Although these sequelae are known to affect thousands of individuals individually, a comprehensive evaluation of all potential long-term effects of infectious diseases has yet to be undertaken. We present a comprehensive literature review delineating the primary sequelae attributable to major infectious diseases, categorized by systems, symptoms, and duration. This compilation serves as a crucial resource, illuminating the long-term ramifications of infectious diseases for healthcare professionals worldwide. Moreover, this review highlights the substantial burden that these sequelae impose on global health and economies, a facet often overshadowed by the predominant focus on the acute phase. Patients are frequently discharged following the resolution of the acute phase, with minimal long-term follow-up to comprehend and address potential sequelae. This emphasizes the pressing need for sustained vigilance, thorough patient monitoring, strategic health management, and rigorous research to understand and mitigate the lasting economic and health impacts of infectious diseases more fully.


Subject(s)
Bacterial Infections , Communicable Diseases , Humans , Communicable Diseases/complications , Causality , Risk Factors
3.
J. bras. pneumol ; J. bras. pneumol;49(6): e20230269, 2023. tab, graf
Article in English | LILACS-Express | LILACS | ID: biblio-1528926

ABSTRACT

ABSTRACT Historically, all efforts against tuberculosis were focused on rapid diagnosis and effective treatment to break the chain of transmission of Mycobacterium tuberculosis. However, in the last few years, more and more evidence has been found on the dramatic consequences of the condition defined as post-tuberculosis lung disease (PTLD). Approximately one third of patients surviving pulmonary tuberculosis face considerable ongoing morbidities, including respiratory impairment, psychosocial challenges, and reduced health-related quality of life after treatment completion. Given the important global and local burden of tuberculosis, as well as the estimated burden of PTLD, the development of a consensus document by a Brazilian scientific society-Sociedade Brasileira de Pneumologia e Tisiologia (SBPT)-was considered urgent for the prevention and management of this condition in order to allocate resources to and within tuberculosis services appropriately and serve as a guide for health care professionals. A team of eleven pulmonologists and one methodologist was created by the SBPT to review the current evidence on PTLD and develop recommendations adapted to the Brazilian context. The expert panel selected the topics on the basis of current evidence and international guidelines. During the first phase, three panel members drafted the recommendations, which were divided into three sections: definition and prevalence of PTLD, assessment of PTLD, and management of PTLD. In the second phase, all panel members reviewed, discussed, and revised the recommendations until a consensus was reached. The document was formally approved by the SBPT in a special session organized during the 2023 SBPT Annual Conference.


RESUMO Historicamente, todos os esforços contra a tuberculose concentraram-se no diagnóstico rápido e no tratamento efetivo para quebrar a cadeia de transmissão do Mycobacterium tuberculosis. No entanto, nos últimos anos, têm sido encontradas mais e mais evidências sobre as dramáticas consequências da condição definida como doença pulmonar pós-tuberculose (DPPT). Aproximadamente um terço dos pacientes que sobrevivem à tuberculose pulmonar enfrenta morbidades consideráveis e persistentes, incluindo comprometimento respiratório, desafios psicossociais e redução da qualidade de vida relacionada à saúde após o término do tratamento. Diante da importante carga global e local da tuberculose, bem como da carga estimada da DPPT, considerou-se urgente o desenvolvimento de um documento de consenso por uma sociedade científica brasileira - a Sociedade Brasileira de Pneumologia e Tisiologia (SBPT) - para a prevenção e manejo dessa condição, a fim de alocar recursos de forma adequada para e nos serviços de tuberculose e servir de guia para os profissionais de saúde. Uma equipe de onze pneumologistas e um metodologista foi criada pela SBPT para revisar as evidências atuais sobre a DPPT e desenvolver recomendações adaptadas ao contexto brasileiro. O painel de especialistas selecionou os temas com base nas evidências atuais e diretrizes internacionais. Durante a primeira fase, três membros do painel redigiram as recomendações, que foram divididas em três seções: definição e prevalência de DPPT, avaliação da DPPT e manejo da DPPT. Na segunda fase, todos os membros do painel analisaram, discutiram e revisaram as recomendações até chegar a um consenso. O documento foi aprovado formalmente pela SBPT em sessão especial organizada durante o Congresso Anual da SBPT de 2023.

4.
Rev. cuba. med. trop ; 72(1): e476, ene.-abr. 2020. tab, graf
Article in Spanish | CUMED, LILACS | ID: biblio-1126703

ABSTRACT

Introducción: La ataxia constituye una alteración en la coordinación de los movimientos, resultado de una disfunción del cerebelo, sus conexiones, así como alteraciones en la médula espinal, nervios periféricos o una combinación de estas condiciones. Las ataxias se clasifican en hereditarias, esporádicas y en adquiridas o secundarias, en las cuales los virus neurotrópicos constituyen los principales causantes. Objetivo: Actualizar los conocimientos relacionados con las ataxias causadas por virus neurotrópicos y los mecanismos neurodegenerativos que pudieran tener relación con la ataxia. Métodos: Se realizó una revisión bibliográfica incluyendo artículos publicados en las principales bases de datos bibliográficas (Web of Sciences, Scopus, SciELO). Se utilizaron las palabras claves: ataxia, virus neurotrópicos, ataxias cerebelosas, ataxias infecciosas, en inglés y español. Análisis e integración de la información: Los virus más conocidos que provocan ataxias infecciosas son el virus de inmunodeficiencia humana, virus del herpes simple, virus del herpes humano tipo 6, virus de la varicela zoster, virus Epstein-Barr, virus del Nilo Occidental, y enterovirus 71, aunque existen otros virus que causan esta afectación. Los mecanismos neuropatogénicos sugeridos son la invasión directa del virus y procesos inmunopatogénicos desencadenados por la infección. Estos virus pueden causar ataxia cerebelosa aguda, ataxia aguda posinfecciosa, síndrome opsoclono-mioclono-atáxico y ataxia por encefalomielitis aguda diseminada. Aunque la mayoría de los reportes de casos informan la evolución satisfactoria de los pacientes, algunos refieren complicaciones neurológicas e incluso la muerte. Conclusiones: Actualmente existe la necesidad de profundizar en el estudio de este tipo de ataxia para favorecer su diagnóstico y tratamiento(AU)


Introduction: Ataxia is an alteration in the coordination of movements caused by a dysfunction of the cerebellum and its connections, as well as alterations in the spinal cord, the peripheral nerves, or a combination of these factors. Ataxias are classified into hereditary, sporadic and acquired or secondary, in which neurotropic viruses are the main causative agents. Objective: Update knowledge about ataxias caused by neurotropic viruses and the neurodegenerative mechanisms which could bear a relationship to ataxia. Methods: A review was conducted of papers published in the main bibliographic databases (Web of Sciences, Scopus, SciELO), using the search terms ataxia, neurotropic virus, cerebellar ataxias, infectious ataxias, in English and in Spanish. Discussion: The best known viruses causing infectious ataxias are the human immunodeficiency virus, herpes simplex virus, human herpesvirus 6, varicella zoster virus, Epstein-Barr virus, Western Nile virus and enterovirus 71, though other viruses may also cause this condition. The neuropathogenic mechanisms suggested are direct invasion of the virus and immunopathogenic processes triggered by the infection. These viruses may cause acute cerebellar ataxia, acute postinfectious ataxia, opsoclonus-myoclonus-ataxia syndrome and ataxia due to acute encephalomyelitis disseminata. Though most case reports describe a satisfactory evolution of patients, some refer to neurological complications and even death. Conclusions: There is a current need to carry out further research about this type of ataxia to improve its diagnosis and treatment(AU)


Subject(s)
Humans , Male , Female , Cerebellar Ataxia/diagnosis , Cerebellar Ataxia/epidemiology , Virulence Factors
5.
BMC Nephrol ; 21(1): 56, 2020 02 24.
Article in English | MEDLINE | ID: mdl-32093686

ABSTRACT

BACKGROUND: Sickle cell disease (SCD) is a highly prevalent genetic disease worldwide. In the natural evolution of SCD, glomerular lesions can develop, presenting histopathological patterns of segmental or focal membranoproliferative glomerulosclerosis, with or without thrombotic microangiopathy. We report two cases of acute post-infectious glomerulonephritis (APIGN), with atypical presentations, in patients with SCD. CASE PRESENTATION: Case 1: An 18-year-old female with SCD presented with a 21-day history of progressive oedema, accompanied by dyspnoea, productive cough, fever, and chest pain. Blood tests showed the following: haemoglobin 6.1 g/dl; leucocytes 18,820 cells/mm3; and creatinine 0.49 mg/dl. A urine sample evidenced leucocyturia and haematuria. The 24-h proteinuria was 8.99 g, serum albumin level was 1.2 g/dl, low serum C3 levels and high levels of anti-streptolysin O. Renal biopsy was consistent with APIGN. The patient was treated with diuretic and anti-proteinuric agents, subsequently evolving to reversal of the renal alterations. Case 2: A 12-year-old male with SCD presented with a 20-day history of a non-productive cough and progressive oedema, together with hypertension. The serum creatinine concentration was 0.48 mg/dl. A urine sample evidenced leukocyturia and haematuria. The 24-h proteinuria was 12.5 g, and the serum albumin level was 2.6 g/dl. The levels of C3 and C4 were normal. Renal biopsy revealed APIGN. The patient was treated with diuretic and anti-proteinuric agents, subsequently evolving reversal of the renal alterations. CONCLUSIONS: The presentation of the two cases reported here are not typical of SCD-related kidney injury. Analysis of the renal biopsy specimens elucidated the diagnosis, affecting the prognosis, because that of APIGN is highly favourable, unlike that of nephrotic syndrome associated with SCD glomerulopathy.


Subject(s)
Anemia, Sickle Cell/complications , Glomerulonephritis/etiology , Kidney/pathology , Nephrotic Syndrome/etiology , Adolescent , Child , Creatinine/blood , Female , Glomerular Filtration Rate , Glomerulonephritis/diagnosis , Hematuria/etiology , Humans , Male , Proteinuria/etiology
6.
J. bras. nefrol ; 41(1): 152-156, Jan.-Mar. 2019. tab, graf
Article in English | LILACS | ID: biblio-1002430

ABSTRACT

ABSTRACT Rapidly progressive glomerulonephritis (RPGN) is a renal disease with an extensive differential diagnosis. This paper reports the case of a 55-year-old female patient diagnosed with Hansen's disease with acute progressive renal impairment after developing lower limb pyoderma. The association between Hansen's and kidney disease has been well documented, with glomerulonephritis (GN) ranked as the most common form of renal involvement. Post-infectious glomerulonephritis (PIGN) in adults has been associated with a number of pathogens occurring in diverse sites. The patient described in this case report had RPGN and biopsy findings suggestive of PIGN with C3 and IgA detected on immunofluorescence and kidney injury secondary to recent infection by Staphylococcus, a well-documented manifestation of renal impairment in patients with Hansen's disease.


RESUMO A Glomerulonefrite Rapidamente Progressiva (GNRP) é um padrão de doença renal com amplo diagnóstico diferencial. O caso reporta uma paciente de 55 anos com deterioração aguda e progressiva da função renal após quadro de piodermite em membro inferior com diagnóstico concomitante de hanseníase. Associação da hanseníase com doença renal é bem descrita, sendo a GN a forma de acometimento renal mais comum. As glomerulonefrites pós-infecciosas (GNPIs) em adultos ocorrem devido a um grande número de patógenos, nos mais diversos sítios. A paciente do caso relatado apresentava quadro de GNRP e achados de biópsia que sugerem GNPI com marcação de C3 e IgA na imunofluorescência, sugestiva de lesão renal secundária a infecção recente por Staphylococcus, uma manifestação bem descrita de doença renal em pacientes com hanseníase.


Subject(s)
Humans , Middle Aged , Complement C3/metabolism , Leprosy, Multibacillary/diagnosis , Acute Kidney Injury/diagnosis , Glomerulonephritis, IGA/diagnosis , Rifampin/therapeutic use , Biopsy , Blood Urea Nitrogen , Fluorescent Antibody Technique , Clofazimine/therapeutic use , Creatinine/blood , Dapsone/therapeutic use , Diagnosis, Differential , Acute Kidney Injury/drug therapy , Glomerulonephritis, IGA/drug therapy , Glucocorticoids/administration & dosage , Glucocorticoids/therapeutic use
7.
Gastroenterol. latinoam ; 29(supl.1): S36-S39, 2018.
Article in Spanish | LILACS | ID: biblio-1117670

ABSTRACT

Infectious gastroenteritis is a risk factor for developing post-infectious functional gastrointestinal disorders (PI-FGDs), mainly irritable bowel syndrome (IBS) and functional dyspepsia (FD). It is a significant subgroup of patients due to frequent episodes of gastrointestinal infections. Symptoms in PI-FGD patients can prevail for more than twelve months, especially if infective agents are bacteria or parasites. Symptoms are indistinguishable from their non-infective equivalents (IBS and FD). Risk factors for developing PI-FGD are: female gender, type and severity of the gastrointestinal infection, high anxiety levels and younger age. Main pathogenic mechanisms are alteration of permeability and immunity. Mucosa inflammation prevails only at early stage; however, with follow-up it can be reduced or normalized. Nevertheless, certain alterations prevail, such as hypersensitivity. These events are treated in the same way as IBS or FD.


La gastroenteritis infecciosa es un factor de riesgo para desarrollar un trastorno digestivo funcional postinfeccioso (TDF-PI), principalmente síndrome de intestino irritable (SII) y dispepsia funcional (DF). Es un subgrupo de pacientes relevante debido a lo frecuente que son las infecciones gastrointestinales. Los síntomas en los pacientes con TDF-PI se pueden prolongar por más de un año, especialmente cuando los agentes infecciosos son bacterias o parásitos. Los síntomas son indistinguibles con respecto a los de sus equivalentes no infecciosos (SII y DF). Los factores de riesgo para desarrollar TDF-PI son el sexo femenino, el tipo y la severidad de la infección gastrointestinal, los niveles altos de ansiedad, y la menor edad. Los principales mecanismos patogénicos son la alteración de la permeabilidad y de inmunidad. La inflamación de la mucosa predomina solo al principio pero con el seguimiento esta disminuye o se normaliza, a pesar de lo cual ciertas alteraciones como la hiperensibilidad permanecen. Estos cuadros se tratan de la misma manera que un SII o DF.


Subject(s)
Humans , Irritable Bowel Syndrome/etiology , Dyspepsia/etiology , Gastroenteritis/complications , Risk Factors , Irritable Bowel Syndrome/physiopathology , Irritable Bowel Syndrome/epidemiology , Dyspepsia/physiopathology , Dyspepsia/epidemiology , Infections/complications
8.
Rev. argent. dermatol ; Rev. argent. dermatol;98(4): 1-10, dic. 2017. ilus
Article in Spanish | LILACS | ID: biblio-897389

ABSTRACT

Se evaluó paciente femenino de 51 años, con antecedentes de diabetes mellitus tipo II e infecciones urinarias a repetición, procedente de la comunidad Mario Briceño Iragorry, quien acude al ambulatorio centro de especialidades "Los Grillitos", de la Corporación de Salud del Estado de Aragua - Venezuela, presentando lesión ulcerada a nivel de hemicadera izquierda, posterior a la colocación vía intramuscular de diclofenac sódico el 28/03/17, el que fue indicado por facultativo para tratar dolor por infección urinaria alta. Posteriormente, a las 24 horas presenta en la zona de la inyección una coloración violácea, induración y mucho dolor, motivo por el que acude nuevamente al facultativo. Se le realizó ecosonograma de partes blandas en región glútea izquierda, reportando imagen heterogénea a predominio hipoecoico con ecos internos de mediana intensidad, que genera reforzamiento posterior de 49x39 mm, con aproximadamente 30 cc de líquido, que correspondería a un proceso inflamatorio e infeccioso (absceso). Posteriormente a la evaluación, se indica antibiótico terapia a base de oxacilina 1 g cada 8 horas vía endovenosa por siete días, además 100 mg cada 12 horas vía oral de nitrofurantoína para el proceso infeccioso urinario, que el urocultivo indica ser sensible a la E. Coli. Al tercer día de la enfermedad actual, se le drena absceso con material purulento aproximadamente 20 cc y cura sucesiva por cinco días, evolucionando satisfactoriamente del proceso infeccioso de partes blandas e infección urinaria.


A 51-year-old female patient with a history of type II diabetes mellitus and recurrent urinary tract infections from the Mario Briceño Iragorry community, attended the outpatient clinic "Los Grillitos" of the health corporation of Aragua Venezuela, with an ulcerated lesion at the left hemi-hip level, following the intramuscular placement of diclofenac sodium on 03/28/17, which was indicated by facultative to treat pain due to high urinary tract infection, afterwards approximately 24 hours presents at the injection site a violet coloration, induration and a lot of pain, which is why she returned to facultative, she performed a soft-tissue echosonogram in the left gluteal region reporting a heterogeneous image to hypoechoic predominance with internal echoes of medium intensity that generates posterior reinforcement which measures 49x39 mm with approximately 30 cc of liquid that could correspond to an inflammatory and infectious process (abscess), post-evaluation is indicated antibiotic therapy based on oxacillin 1 g every 8 hours intravenous route for seven days plus 100 mg every 12 hours oral route of nitrofurantoin for the urinary infectious process that the urine culture indicates to be sensitive E. coli, the third day of illness is drained abscess purulent material approximately 20 cc and successive cure for five days. Satisfactory evolution of the infectious process of soft tissue and urinary tract infection.

9.
Neumol. pediátr. (En línea) ; 12(4): 175-181, oct. 2017. ilus
Article in Spanish | LILACS | ID: biblio-999167

ABSTRACT

Post-infectious bronchiolitis obliterans (PIBO) is a lung disease characterized by chronic airflow limitation associated with small airway fibrosis and obliteration, caused by viral infection in the first years of life. According to the current clinical guidelines in our country, the bases of its treatment involve pharmacological and non-pharmacological strategies. Among non-pharmacological strategies, pulmonary rehabilitation (PR) is the standout, which consists of diagnostic and therapeutic management designed to evaluate and reverse function deterioration, and aimed at improving the quality of life and the prognosis of these patients.The objective of this review is to describe and discuss the components associated with pulmonary rehabilitation of PIBO patients, emphasizing the properties and attributes of the evaluation methods and the main treatment strategies that contribute to improving these patients' functionality


La bronquiolitis obliterante post infecciosa (BOPI) es una enfermedad pulmonar caracterizada por limitación crónica al flujo de aire asociado a fibrosis y obliteración de la vía aérea pequeña, que se produce como consecuencia de un cuadro infeccioso de origen viral durante los primeros años de vida. De acuerdo a la guía clínica vigente en nuestro país, las bases de su tratamiento se sustentan en estrategias farmacológicas y no farmacológicas. Entre las estrategias no farmacológicas destaca la rehabilitación respiratoria (RR), que se estructura a partir de la ejecución de protocolos de intervención con fines diagnósticos y terapéuticos, dirigidos a evaluar y revertir el deterioro funcional, teniendo como propósito central el mejorar la calidad de vida y el pronóstico de estos pacientes. El objetivo de la presente revisión es describir y discutir los componentes asociados a la rehabilitación pulmonar de los pacientes con BOPI, haciendo énfasis en las propiedades y atributos de los métodos de evaluación y en las principales estrategias de tratamiento que contribuyen a mejorar la funcionalidad de estos pacientes


Subject(s)
Humans , Child , Bronchiolitis Obliterans/rehabilitation , Bronchiolitis Obliterans/virology , Quality of Life , Respiratory Function Tests , Respiratory Therapy , Respiratory Tract Infections/complications , Breathing Exercises , Bronchiolitis Obliterans/physiopathology , Bronchiolitis Obliterans/microbiology , Exercise Tolerance , Muscle Strength
10.
Gastroenterology ; 152(5): 1042-1054.e1, 2017 04.
Article in English | MEDLINE | ID: mdl-28069350

ABSTRACT

BACKGROUND & AIMS: Foodborne illness affects 15% of the US population each year, and is a risk factor for irritable bowel syndrome (IBS). We evaluated risk of, risk factors for, and outcomes of IBS after infectious enteritis. METHODS: We performed a systematic review of electronic databases from 1994 through August 31, 2015 to identify cohort studies of the prevalence of IBS 3 months or more after infectious enteritis. We used random-effects meta-analysis to calculate the summary point prevalence of IBS after infectious enteritis, as well as relative risk (compared with individuals without infectious enteritis) and host- and enteritis-related risk factors. RESULTS: We identified 45 studies, comprising 21,421 individuals with enteritis, followed for 3 months to 10 years for development of IBS. The pooled prevalence of IBS at 12 months after infectious enteritis was 10.1% (95% confidence interval [CI], 7.2-14.1) and at more than 12 months after infectious enteritis was 14.5% (95% CI, 7.7-25.5). Risk of IBS was 4.2-fold higher in patients who had infectious enteritis in the past 12 months than in those who had not (95% CI, 3.1-5.7); risk of IBS was 2.3-fold higher in individuals who had infectious enteritis more than 12 months ago than in individuals who had not (95% CI, 1.8-3.0). Of patients with enteritis caused by protozoa or parasites, 41.9% developed IBS, and of patients with enteritis caused by bacterial infection, 13.8% developed IBS. Risk of IBS was significantly increased in women (odds ratio [OR], 2.2; 95% CI, 1.6-3.1) and individuals with antibiotic exposure (OR, 1.7; 95% CI, 1.2-2.4), anxiety (OR, 2; 95% CI, 1.3-2.9), depression (OR, 1.5; 95% CI, 1.2-1.9), somatization (OR, 4.1; 95% CI, 2.7-6.0), neuroticism (OR, 3.3; 95% CI, 1.6-6.5), and clinical indicators of enteritis severity. There was a considerable level of heterogeneity among studies. CONCLUSIONS: In a systematic review and meta-analysis, we found >10% of patients with infectious enteritis develop IBS later; risk of IBS was 4-fold higher than in individuals who did not have infectious enteritis, although there was heterogeneity among studies analyzed. Women-particularly those with severe enteritis-are at increased risk for developing IBS, as are individuals with psychological distress and users of antibiotics during the enteritis.


Subject(s)
Enteritis/epidemiology , Foodborne Diseases/epidemiology , Irritable Bowel Syndrome/epidemiology , Anti-Bacterial Agents/therapeutic use , Anxiety/epidemiology , Anxiety Disorders/epidemiology , Bacterial Infections/epidemiology , Depression/epidemiology , Enteritis/drug therapy , Enteritis/microbiology , Female , Foodborne Diseases/drug therapy , Foodborne Diseases/microbiology , Humans , Intestinal Diseases, Parasitic/epidemiology , Male , Neuroticism , Odds Ratio , Prevalence , Risk Factors , Severity of Illness Index , Sex Factors , Somatoform Disorders/epidemiology
11.
Rev. argent. dermatol ; Rev. argent. dermatol;97(2): 57-63, jun. 2016. ilus
Article in Spanish | LILACS | ID: biblio-843082

ABSTRACT

Comunicamos una paciente femenina de 24 años de edad, natural y procedente de la localidad, quien consulta en el mes de enero de 2016 al Centro Integral de Especialidades “Los Grillitos”, CORPOSALUD. Municipio Mario Briceño Iragorry por presentar lesión ulcerosa a nivel de hemicadera derecha, cuya aparición fue posterior a la administración de medicamentos vía intramuscular (ampolla de amikacina). El tratamiento aplicado fue debido a una infección vaginal que presentó en el mes de septiembre 2015, cuyo cultivo resultó sensible a este antibiótico; comenzó a presentar un área endurecida color violáceo, hasta convertirse en una úlcera en el mes de diciembre 2015. Por este motivo, acude al médico quien indica ecosonograma de partes blandas (27/1/2016), informando: úlcera de 29 mm asociado a celulitis post infecciosa a administración medicamentosa, en hemicadera derecha y hematoma, organizado en hemicadera izquierda (0,25 cc); se realiza cultivo (27/1/2016) reportando presencia de Acinetobacter baumani complex sensible a la ciprofloxacina, la que se indica, observándose actualmente mejoría clínica de la lesión.


It is 24 years female patient age and naturally from the locality, who consults in January 2016 to Integral Center Specialty "The Grillitos" Corposalud. Municipio Mario Briceño Iragorry to present Injury ulcer type level right hemi hip whose appearance was after drug administration (vial amikacin) treatment applied due to a vaginal infection present in the month of September 2015 whose culture was sensitive to this antibiotic, he began to present purple colored hardened to become ulcerated area in December 2015. Which is why go to the doctor who said soft tissue sonography (01/27/2016) ulcer reporting 29 mm associated with post-infectious cellulitis to drug administration right hemi hip and a left organized hematoma (0.25 cc); culture (01.27.2016) is perform reporting presence of Acinetobacter baumani sensitive Ciprofloxacin treatment indicated Complex currently observed clinical improvement of the injury.

12.
Respirology ; 20(6): 982-6, 2015 Aug.
Article in English | MEDLINE | ID: mdl-25939617

ABSTRACT

BACKGROUND AND OBJECTIVE: Post-infectious bronchiolitis obliterans (PIBO) is a severe disorder following acute lower pulmonary infection in young children, especially caused by adenovirus. Mannose-binding lectin (MBL) deficiency arising from polymorphisms in the coding and non-coding region on the MBL2 gene has been associated with more frequent and severe respiratory infections. Our aim was to evaluate the influence of MBL variants in the susceptibility and evolution of children with PIBO. METHODS: One hundred eleven children with PIBO diagnosis were studied. The coding A, B, D and X promoter variants of MBL2 gene were assessed by PCR-RFLP. B and D alleles were pooled as O. The combined genotypes A/A and YA/O were grouped as sufficient MBL (sMBL), and O/O and XA/O as insufficient MBL (iMBL) groups. To evaluate the frequency of MBL2 polymorphisms in the general population, we studied DNA samples from 127 healthy donors from the blood bank of the hospital (control group). RESULTS: iMBL variants were significantly more frequent in PIBO children compared with controls (21.6% vs 10.2%, P = 0.01). PIBO patients with iMBL required intensive care unit (P = 0.001) and mechanical assistance at the moment of viral injury (P = 0.001) more frequently than those with sMBL. CONCLUSIONS: Insufficiency of MBL was more common in PIBO children than in healthy controls. This genetic condition was significantly associated with more severe initial disease, illustrating the relevance of innate immune defence factors prior to the maturation of the adaptative immune system.


Subject(s)
Bronchiolitis Obliterans/epidemiology , Mannose-Binding Lectin/deficiency , Metabolism, Inborn Errors/epidemiology , Adolescent , Argentina/epidemiology , Bronchiolitis Obliterans/etiology , Child , Child, Preschool , Disease Susceptibility , Female , Gene Frequency , Genetic Variation , Genotype , Humans , Infant , Male , Mannose-Binding Lectin/genetics , Metabolism, Inborn Errors/genetics , Polymorphism, Genetic , Respiratory Tract Infections/complications
13.
Rev. habanera cienc. méd ; 14(2): 159-167, mar.-abr. 2015.
Article in Spanish | CUMED | ID: cum-67960

ABSTRACT

Introducción: el virus de la Varicela es causante de varias complicaciones en el curso de la misma, entre ellas está la Mielitis transversa. Su mecanismo es autoinmune y se reporta que 30 por ciento de los casos evoluciona de forma crónica con serias secuelas invalidantes.Objetivo: presentar una paciente con diagnóstico de Mielitis transversa aguda como complicación en el curso de la Varicela en el adulto. Presentación del caso: mujer de 45 años sin antecedentes patológicos y con 15 días de evolución con Varicela. Las manifestaciones clínicas neurológicas, el estudio del Líquido Cefalorraquídeo, las imágenes de la Resonancia Magnética Nuclear, la velocidad de conducción nerviosa, la respuesta a la terapéutica impuesta y la evolución apoyaron el diagnóstico.Conclusiones: la Mielitis transversa aguda es una complicación poco frecuente de la Varicela en el adulto. Con un diagnóstico temprano y un tratamiento oportuno la evolución puede ser favorable(AU)


Introduction: chickenpox virus causes several clinical complications during the course of the disease; among them is transverse Myelitis. Its mechanism is auto immune and 30 percent is reported to evolve to a chronic presentation with invalidating consequences. Objective: to show a patient with an acute transverse Myelitis as a complication of the course of the chickenpox in an adult. Case Presentation: we show a 45 years old female, without previous history of a disease and 15 days of evolution of the chickenpox. The clinical neurological manifestations supported by the study of the Cerebrospinal Fluid, the images of the Nuclear Magnetic Resonance , the speed of the nervous conduction, the response to the therapeutics and its evolution support the diagnosis.Conclusions: transverse Myelitis is a non-frequent complication of chickenpox in adults, with an early diagnosis and an appropriate treatment, the evolution could be positive(AU)


Subject(s)
Humans
15.
Pediátr. Panamá ; 43(2): 25-34, Agosto - Septiembre 2014.
Article in Spanish | LILACS | ID: biblio-848830

ABSTRACT

Presentamos dos casos de bronquiolitis obliterante post infecciosa, su manejo y evolución. La bronquiolitis obliterante es una forma rara de enfermedad pulmonar obstructiva crónica que resulta de una lesión grave en la vía respiratoria inferior que lleva a grados variables de inflamación y fibrosis de la vía aérea pequeña. La bronquiolitis obliterante post infecciosa es la forma más común en los niños. Su epidemiología está directamente relacionada con la epidemiología de las infecciones respiratorias virales graves de los lactantes, especialmente las causadas por el adenovirus. No existen síntomas ni signos específicos sin embargo, los pacientes tienen sibilancias persistentes, taquipnea, disnea y tos por semanas o meses después del insulto infeccioso inicial. El diagnóstico se puede establecer, de manera confiable, sobre la base de una presentación clínica consistente, la identificación del virus , hallazgos característicos en los estudios de imágenes , demostración de una obstrucción fija de la vía aérea en las pruebas de función pulmonar en los pacientes colaboradores y en algunos casos se requiere la confirmación histológica mediante biopsia pulmonar. El tratamiento es de apoyo, basado en oxigenoterapia, corticoides inhalados, inmunomoduladores, broncodilatadores y glucocorticoides orales durante las exacerbaciones respiratorias, uso precoz de antibióticos durante las infecciones agudas, fisioterapia respiratoria y apoyo nutricional. La mortalidad puede ser alta durante la infección aguda por adenovirus pero, una vez establecida la enfermedad, la mortalidad disminuye. Sin embargo, la morbilidad es alta dada las hospitalizaciones frecuentes por infecciones respiratorias y por las exacerbaciones obstructivas durante los primeros años de la enfermedad.


We report two cases of post infectious bronchiolitis obliterans its management and evolution. Bronchiolitis Obliterans is a rare form of chronic obstructive lung disease secondary to a sever insult to the lower respiratory tract, resulting in fibrosis of the small airways. In children, the most common presentation is the postinfectious variant, closely related to a severe viral infection. Thus, although its prevalence is not known, its epidemiology is directly related to the epidemiology of severe viral respiratory tract infections in young children, particularly of adenoviral aetiology. There are no specific signs and symptoms but the patients have persistent wheezing, tachypnea, dyspnea and cough that persists for weeks or months after the initial lung injury. A comprehensive approach utilizing a combination of history and physical exam, virus identification, characteristic findings in imaging studies, the presence of fixed airflow obstruction in pulmonary function tests, and in some cases the histopathological study of lung tissue obtained by lung biopsy is essential to arriving at the correct diagnosis. Treatment is mainly supportive based on oxygen supplementation, inhaled corticosteroids, short-acting bronchodilators and oral corticosteroids to treat respiratory exacerbations and early use of antibiotics for the treatment of acute infections, chest physiotherapy and nutritional support. During the acute infection, mortality can be high but, once the disease is established, it has a low mortality rate. Morbidity, on the other hand, is high with frequent hospitalizations due to secondary respiratory infections and obstructive exacerbations during the first years of the disease.

16.
Rev Gastroenterol Mex ; 79(2): 96-134, 2014.
Article in English, Spanish | MEDLINE | ID: mdl-24857420

ABSTRACT

BACKGROUND: Post-infectious irritable bowel syndrome (PI-IBS) prevalence, small intestinal bacterial overgrowth (SIBO), altered microbiota, low-grade inflammation, and antibiotic therapy in IBS are all controversial issues. AIMS: To conduct an evidence-based review of these factors. METHODS: A review of the literature was carried out up to July 2012, with the inclusion of additional articles as far as August 2013, all of which were analyzed through the Oxford Centre for Evidence-Based Medicine (OCEBM) system. RESULTS: 1.There is greater SIBO probability in IBS when breath tests are performed, but prevalence varies widely (2-84%). 2.The gut microbiota in individuals with IBS is different from that in healthy subjects, but a common characteristic present in all the patients has not been established. 3.The incidence and prevalence of PI-IBS varies from 9-10% and 3-17%, respectively, and the latter decreases over time. Bacterial etiology is the most frequent but post-viral and parasitic cases have been reported. 4.A sub-group of patients has increased enterochromaffin cells, intraepithelial lymphocytes, and mast cells in the intestinal mucosa, but no differences between PI-IBS and non-PI-IBS have been determined. 5.Methanogenic microbiota has been associated with IBS with constipation. 6.Rifaximin at doses of 400mg TID/10days or 550mg TID/14days is effective treatment for the majority of overall symptoms and abdominal bloating in IBS. Retreatment effectiveness appears to be similar to that of the first cycle. CONCLUSIONS: Further studies are required to determine the nature of the gut microbiota in IBS and the differences in low-grade inflammation between PI-IBS and non-PI-IBS. Rifaximin has shown itself to be effective treatment for IBS, regardless of prior factors.


Subject(s)
Gastrointestinal Diseases/microbiology , Gastrointestinal Diseases/pathology , Irritable Bowel Syndrome/microbiology , Irritable Bowel Syndrome/pathology , Microbiota , Evidence-Based Medicine , Humans
17.
Neumol. pediátr. (En línea) ; 9(1): 27-30, 2014. graf, ilus, tab
Article in Spanish | LILACS | ID: lil-773782

ABSTRACT

Pulmonary rehabilitation is part of bronchiolitis obliterans comprehensive treatment. However, ventilatory constraints, often observed in these patients, difficult to achieve appropriate workloads in order to get physiological adaptations which increase the functional capacity and improve the performance in their daily life activities. In this case report, we describe the effects of non-invasive ventilation (NIV) during exercise on an adolescent with BO. He showed less dyspnea, fatigue legs, he improved oxygenation and endurance time. These results show the potential usefulness of NIV as an adjunct to exercise in this group of patients. However, further studies are needed to confirm these hypotheses.


La rehabilitación respiratoria forma parte del tratamiento de la bronquiolitis obliterante (BO) post-infecciosa. Sin embargo, la limitación ventilatoria, a menudo observada durante el ejercicio, dificulta el logro de cargas de trabajo adecuada para alcanzar adaptaciones fisiológicas que permitan incrementar la capacidad funcional y mejorar el desempeño en sus actividades cotidianas. En el presente caso clínico se muestran los efectos de la ventilación no invasiva (VNI) sobre el rendimiento físico de un adolescente con BO, observándose disminución de la disnea, fatiga de piernas, mejorando la oxigenación y el tiempo de resistencia durante el ejercicio asistido. Estos resultados muestran la posible utilidad de esta herramienta como coadyuvante al ejercicio en este grupo de pacientes. No obstante, futuros estudios clínicos son necesarios para confirmar estas hipótesis.


Subject(s)
Humans , Male , Adolescent , Child , Bronchiolitis Obliterans/physiopathology , Bronchiolitis Obliterans/rehabilitation , Exercise/physiology , Noninvasive Ventilation/methods
18.
Acta neurol. colomb ; 29(4): 289-294, oct.-dic. 2013. ilus
Article in Spanish | LILACS | ID: lil-698719

ABSTRACT

La Leucoencefalitis Hemorrágica Aguda o enfermedad de Hurst es una enfermedad rara, caracterizada clínicamente por inicio súbito, curso clínico severo, usualmente fatal que se presenta posterior a una infección viral o vacunación. Patológicamente se caracteriza por desmielinización perivenular y necrosis hemorrágica difusa del sistema nervioso central. Se considera que representa una forma hiperaguda y severa de la Encefalomielitis Aguda Diseminada, la cual es una entidad inflamatoria con una base fisiopatológica autoinmune postinfecciosa. A continuación, se expone el caso de una paciente adulta, que ingresó al servicio de urgencias con cuadro clínico típico de migraña y antecedente de cefaleas previas de similares características. Quien doce horas posterior a su ingreso desarrolló de forma rápidamente progresiva depresión del estado de conciencia, signos neurológicos focales y signos de hipertensión de fosa posterior, que llevaron a desenlace fatal en tan solo 96 horas del inicio del cuadro clínico con hallazgos patológicos postmortem que confirman leucoencefalitis hemorrágica aguda. Se revisan las características clínicas, los hallazgos radiológicos y patológicos de esta entidad clínico-patológica poco común.


Acute hemorrhagic leukoencephalitis or Hurst disease is a rare disorder characterized by its severe neurological involvement, rapid progression and fatal outcome in a few days. The disease is usually a post infectious condition. Under microscope, it is identified by a perivenular demyelination and a diffuse hemorrhagic necrosis. This entity is thought to represent a hyperacute severe form of acute disseminated encephalomyelitis, which is an inflammatory autoimmune post infectious disorder. We describe the case of an adult woman, who visits the emergency room with migraine-like symptoms and a previous clinical history of similar headaches. Twelve hours later she developed focal neurologic findings, stupor and signs of endocraneal hypertension, her clinical status continued to worsen and in 96 hours she succumbed. The autopsy confirm acute hemorrhagic Leukoencephalitis. Reviewed clinical, radiological and pathological characteristics of this uncommon disease.


Subject(s)
Humans , Leukoencephalitis, Acute Hemorrhagic , Encephalomyelitis, Acute Disseminated
19.
J. bras. med ; 101(3): 7-13, 2013. tab
Article in Portuguese | LILACS | ID: lil-698223

ABSTRACT

A síndrome do intestino irritável (SII) é um distúrbio funcional do trato gastrointestinal, caracterizado por dor abdominal e alterações do hábito intestinal, não explicadas por anormalidades bioquímicas ou orgânicas. Embora a maioria dos pacientes relate início insidioso dos sintomas, em um subgrupo eles aparecem após episódio de gastroenterite aguda, denominada SII pós-infecciosa (SII-PI). Os agentes infecciosos envolvidos incluem vírus, parasitas e bactérias patogênicas. O tratamento da SII-PI é semelhante ao da SII idiopática. Antibióticos e probióticos são terapias promissoras


Irritable bowel syndrome (IBS) is a funcional gastrointestinal disorder characterized by abdominal pain and changes in bowel habits, not explained by any organic or biochemical abnormalities. Although most patients describe an insidious onset of symptoms, a subgroup of individuals describes the onset of IBS symptoms following an episode of acute gastroenteritis, know as post-infectious IBS (PI-IBS). The infectious agents involved in the development of PI-IBS include pathogenic bacteria, parasites and viruses. Treatment of PI-IBS is similar to that idiopathic IBS. Antibiotics and probiotics appear to represent promising therapies in PI-IBS


Subject(s)
Humans , Male , Female , Abdominal Pain/etiology , Irritable Bowel Syndrome/physiopathology , Irritable Bowel Syndrome/drug therapy , Constipation , Diarrhea , Gastrointestinal Agents/therapeutic use , Gastroenteritis/complications , Intestine, Small/microbiology , Mesalamine/therapeutic use , Probiotics/therapeutic use , Gastrointestinal Tract/physiopathology
20.
Gac. méd. boliv ; 28(2): 61-66, 2005. ilus
Article in Spanish | LILACS | ID: lil-737715

ABSTRACT

Los pacientes con endocarditis infecciosa pueden desarrollar tres diferentes formas de enfermedad renal: Glomerulonefritis postinfecciosa mediada por complejos inmunes, nefritis intersticial aguda inducida por drogas o necrosis tubular aguda por aminoglucósidos y la enfermedad embólica renal. La glomerulonefritis mediada por inmunocomplejos es similar a la glomerulonefritis post Estreptocócica o la glomerulonefritis membranoproliferativa con antigenemia larga y persistente. Las manifestaciones clínicas son similares a las de aquellos pacientes con otras formas de glomerulonefritis aguda. Presentamos el caso de una paciente que cumplió los requisitos para entrar dentro el grupo de glomerulonefritis por complejos inmunes, destacando el hecho de presentar alteraciones en la función renal y sedimento urinario disipadas con la resolución de la patología de base.


Patients with infective endocarditis can develop three different forms of renal disease: post infectious immune complex mediated glomerulonephritis, drug induced acute intersticial nephritis or acute tubular necrosis due to aminoglucoside toxicity and renal embolic disease. Inmune complex glomerulonephritis is similar to post estreptococal glomerulonephritis or membrano proliferative glomerulonephritis with long standing and persistent antigenemia. The clinical manifestations are similar to those of other forms of glomerulonephritis. We present the case of a patient who fulfilled most criteria of immune complex mediated glomerulonephritis. emphasizing the fact that the alterations in renal function and urinary sediment resolved with the resolution of the primary disease.


Subject(s)
Glomerulonephritis
SELECTION OF CITATIONS
SEARCH DETAIL